Quality competition among hospitals, induced by patients freely choosing their hospital in a price regulated market … improvements. Patients respond to service quality and specialization and thus, quality competition seems to be present. Colorectal …. Furthermore, we find that competition on quality for colorectal resection is rather local, whereas for knee replacement we observe …

quality of service. To test these reasonings, the paper draws empirical evidence from the health systems of Australia, Canada …

We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using …-sample of off-patent products. First, we construct a vertical differentiation model to analyze the impact of regulation on … a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub …

generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than …

We analyze the impact of national pharmaceutical regulation on the launch delay of new chemical entities approved by … countries (18% for Portugal and 19% for Greece). This difference accrues from both price regulation and market attractiveness …

This paper studies the effect of a change in the mandatory manufacturer rebate on wholesale prices for pharmaceuticals … on competition by parallel imports. First, it analyzes the effect of a manufacturer rebate on competition by parallel …. Using a data set with prescription drugs with competition from parallel imports, I estimate the effect of the change in the …

pharmaceuticals on competition by parallel imports. First, I analyze the effect of a manufacturer rebate on competition by parallel … data set with prescription drugs with competition from parallel imports, I estimate the effect of the change in the … manufacturer rebate on competition by parallel imports. Estimation results suggest that an increase in the manufacturer rebate has …

Many countries with national health care providers and health insurances regulate the market for pharmaceuticals to … drug substitution and competition. Since 2006, Germany follows an innovative approach by differentiating drug co … potential reductions in co-payments. We refer to the latter result as the co-payment exemption paradox. Our competition proxy …